Whole-exome sequencing (WES) predicting two extreme phenotypes of response to VEGF-targeted therapies (VEGF-TT) in patients with metastatic clear cell renal cell carcinoma (mRCC) Meeting Abstract


Authors: Fay, A. P.; Van Allen, E. M.; Murray, B.; Albiges, L.; Signoretti, S.; Ho, T. H.; Hakimi, A. A.; Mickey, S. S.; Stanton, M. L.; Bellmunt, J.; McDermott, D. F.; Atkins, M. B.; Garraway, L. A.; Kwiatkowski, D. J.; Choueiri, T. K.
Abstract Title: Whole-exome sequencing (WES) predicting two extreme phenotypes of response to VEGF-targeted therapies (VEGF-TT) in patients with metastatic clear cell renal cell carcinoma (mRCC)
Meeting Title: 2015 Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 7 Suppl.
Meeting Dates: 2015 Feb 26-28
Meeting Location: Orlando, FL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-03-01
Language: English
ACCESSION: WOS:000356886700419
PROVIDER: wos
DOI: 10.1200/jco.2015.33.7_suppl.422
Notes: Meeting Abstract: 422 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Abraham Ari Hakimi
    324 Hakimi